8-11564284-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000526097.1(BLK):​n.1634C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 779,138 control chromosomes in the GnomAD database, including 76,725 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.44 ( 15566 hom., cov: 35)
Exomes 𝑓: 0.42 ( 61159 hom. )

Consequence

BLK
ENST00000526097.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0230

Publications

11 publications found
Variant links:
Genes affected
BLK (HGNC:1057): (BLK proto-oncogene, Src family tyrosine kinase) This gene encodes a nonreceptor tyrosine-kinase of the src family of proto-oncogenes that are typically involved in cell proliferation and differentiation. The protein has a role in B-cell receptor signaling and B-cell development. The protein also stimulates insulin synthesis and secretion in response to glucose and enhances the expression of several pancreatic beta-cell transcription factors. [provided by RefSeq, Aug 2010]
BLK Gene-Disease associations (from GenCC):
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young type 11
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • monogenic diabetes
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-11564284-C-T is Benign according to our data. Variant chr8-11564284-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 361500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.902 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BLKNM_001715.3 linkc.*176C>T 3_prime_UTR_variant Exon 13 of 13 ENST00000259089.9 NP_001706.2 P51451Q05D26

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BLKENST00000259089.9 linkc.*176C>T 3_prime_UTR_variant Exon 13 of 13 1 NM_001715.3 ENSP00000259089.4 P51451

Frequencies

GnomAD3 genomes
AF:
0.437
AC:
66462
AN:
152096
Hom.:
15539
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.473
Gnomad AMI
AF:
0.565
Gnomad AMR
AF:
0.522
Gnomad ASJ
AF:
0.355
Gnomad EAS
AF:
0.923
Gnomad SAS
AF:
0.507
Gnomad FIN
AF:
0.430
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.358
Gnomad OTH
AF:
0.426
GnomAD2 exomes
AF:
0.483
AC:
61432
AN:
127312
AF XY:
0.476
show subpopulations
Gnomad AFR exome
AF:
0.482
Gnomad AMR exome
AF:
0.597
Gnomad ASJ exome
AF:
0.340
Gnomad EAS exome
AF:
0.923
Gnomad FIN exome
AF:
0.412
Gnomad NFE exome
AF:
0.360
Gnomad OTH exome
AF:
0.429
GnomAD4 exome
AF:
0.416
AC:
261107
AN:
626924
Hom.:
61159
Cov.:
8
AF XY:
0.417
AC XY:
138457
AN XY:
331880
show subpopulations
African (AFR)
AF:
0.472
AC:
8014
AN:
16970
American (AMR)
AF:
0.590
AC:
20266
AN:
34378
Ashkenazi Jewish (ASJ)
AF:
0.352
AC:
7098
AN:
20170
East Asian (EAS)
AF:
0.919
AC:
29555
AN:
32152
South Asian (SAS)
AF:
0.492
AC:
30931
AN:
62920
European-Finnish (FIN)
AF:
0.407
AC:
13414
AN:
32934
Middle Eastern (MID)
AF:
0.360
AC:
1511
AN:
4202
European-Non Finnish (NFE)
AF:
0.350
AC:
136453
AN:
390308
Other (OTH)
AF:
0.422
AC:
13865
AN:
32890
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
8639
17278
25916
34555
43194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1886
3772
5658
7544
9430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.437
AC:
66542
AN:
152214
Hom.:
15566
Cov.:
35
AF XY:
0.447
AC XY:
33268
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.473
AC:
19652
AN:
41528
American (AMR)
AF:
0.522
AC:
7989
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
1233
AN:
3472
East Asian (EAS)
AF:
0.923
AC:
4780
AN:
5176
South Asian (SAS)
AF:
0.505
AC:
2438
AN:
4826
European-Finnish (FIN)
AF:
0.430
AC:
4558
AN:
10608
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.358
AC:
24372
AN:
67996
Other (OTH)
AF:
0.434
AC:
915
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1929
3858
5787
7716
9645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.393
Hom.:
7121
Bravo
AF:
0.452
Asia WGS
AF:
0.698
AC:
2424
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Maturity-onset diabetes of the young type 11 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Systemic lupus erythematosus Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

BLK gene is associated with Systemic lupus erythematosus, sjogren's syndrome and other systemic inflammatory conditions. However no sufficient evidence is found to ascertain the role of this particular variant rs1042689, yet. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
8.2
DANN
Benign
0.80
PhyloP100
0.023
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042689; hg19: chr8-11421793; API